The following is a comparison broken out by mechanism and total between extramural dollars spent versus Intramural Research Program (IRP) and Research Management and Support (RMS).
Download the Data
*Fiscal years 2023 through 2017 include Cancer Moonshot funding appropriated that fiscal year and exclude all carryover obligations for fiscal years 2023 through 2018.
FY 2017-2023 Total NCI Funding
(Dollars in Millions)
| 2017* |
2018* |
2019* |
2020* |
2021* |
2022* |
2023* |
2017-2023 % Change |
|---|
| *Fiscal years 2023 through 2017 include Cancer Moonshot funding appropriated that fiscal year and exclude all carryover obligations for fiscal years 2023 through 2018. |
| $5,636.4 |
$5,927.7 |
$5,992.3 |
$6,383.4 |
$6,442.7 |
$6,833.7 |
$7,186.8 |
5.2% |
FY 2017-2023 Extramural Funding
(Dollars in Millions)
| Mechanism |
2017* |
2018* |
2019* |
2020* |
2021* |
2022* |
2023* |
2017-2023 % Change |
|---|
| *Fiscal years 2023 through 2017 include Cancer Moonshot funding appropriated that fiscal year and exclude all carryover obligations for fiscal years 2023 through 2018. |
| Research Project Grants |
$2,278.4 |
$2,450.6 |
$2,541.7 |
$2,749.4 |
$2,822.4 |
$2,966.5 |
$3,145.2 |
6.0% |
| Cancer Centers |
313.0 |
331.4 |
337.1 |
382.0 |
344.7 |
339.7 |
353.5 |
4.1% |
| SPOREs |
111.4 |
115.8 |
110.7 |
113.2 |
119.6 |
128.2 |
124.1 |
-3.2% |
| Other P50s/P20s |
1.3 |
0.0 |
7.4 |
7.9 |
3.3 |
13.2 |
5.3 |
-59.8% |
| Other Specialized Centers |
135.6 |
178.3 |
200.8 |
110.7 |
95.9 |
106.0 |
141.5 |
33.5% |
| Other Research Grants |
481.9 |
537.9 |
506.8 |
548.1 |
556.2 |
624.8 |
621.5 |
-0.5% |
| NRSA |
77.6 |
82.4 |
87.0 |
96.4 |
93.0 |
91.1 |
90.3 |
-0.9% |
| R&D Contracts |
880.4 |
825.4 |
768.1 |
823.0 |
812.2 |
835.8 |
899.1 |
7.6% |
| Buildings & Facilities |
30.0 |
18.0 |
18.0 |
30.0 |
30.0 |
30.0 |
30.0 |
0.0% |
| Total Extramural Funds |
$4,309.7 |
$4,539.8 |
$4,577.5 |
$4,860.7 |
$4,877.3 |
$5,135.3 |
$5,410.5 |
5.4% |
FY 2017-2023 Intramural and RMS Funding
(Dollars in Millions)
| Mechanism |
2017* |
2018* |
2019* |
2020* |
2021* |
2022* |
2023* |
2017-2023 % Change |
|---|
| *Fiscal years 2023 through 2017 include Cancer Moonshot funding appropriated that fiscal year and exclude all carryover obligations for fiscal years 2023 through 2018. |
| Intramural Research |
$899.7 |
$945.5 |
$964.9 |
$1,072.6 |
$1,102.5 |
$1,230.4 |
$1,278.5 |
3.9% |
| RMS |
427.0 |
442.4 |
449.9 |
450.0 |
462.9 |
468.0 |
497.8 |
6.4% |
| Total IRP & RMS Funds |
$1,326.7 |
$1,387.9 |
$1,414.8 |
$1,522.6 |
$1,565.4 |
$1,698.4 |
$1,776.3 |
4.6% |
